Deficit of brain and skeletal muscle bioenergetics in progressive supranuclear palsy shown in vivo by phosphorus magnetic resonance spectroscopy

Movement Disorders

Volumn 15, Issue 5, 2000, Pages 889-893

  Rodríguez, Manuel ^a,b   Abdala, Patricio ^a   Obeso, José A ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

31P MR spectroscopy; Progressive supranuclear palsy

Indexed keywords

ADENOSINE DIPHOSPHATE; CREATINE PHOSPHATE; MAGNESIUM ION; PHOSPHATE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BIOENERGY; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; EXERCISE; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; IN VIVO STUDY; MALE; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REST; SKELETAL MUSCLE; SPECTROSCOPY;

ADENOSINE DIPHOSPHATE; AGED; BRAIN; CASE-CONTROL STUDIES; ENERGY METABOLISM; EXERCISE; FEMALE; HUMAN; LEG; MAGNESIUM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGE; MUSCLE, SKELETAL; OCCIPITAL LOBE; PHOSPHORUS; SUPPORT, NON-U.S. GOV'T; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0033819674     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200009)15:5<889::AID-MDS1020>3.0.CO;2-T     Document Type: Article

References (19)

1. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop
2. The clinical and pathologic hallmarks of progressive supranuclear palsy
3. Movement disorders and mitochondrial dysfunction
4. Muscle mitochondrial ATP production in progressive supranuclear palsy
5. Failure of brain and skeletal muscle energy metabolism in multiple system atrophy shown by in vivo phosphorous MR spectroscopy
6. Phosphorus MR spectroscopy in multiple system atrophy and Parkinson's disease
7. 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease
8. 31P-MRS probes and localization techniques in a whole-body imager/spectrometer
9. Low brain intracellular free magnesium in mitochondrial cytopathies
10. In vivo assessment of human skeletal muscle mitochondria respiration in health and disease
11. Phospholipid abnormalities in early Alzheimer's disease. In vivo phosphorus 31 magnetic resonance spectroscopy
12. An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET
13. Frontal lobe phosphorus metabolism and neuropsychological function in aging and in Alzheimer's disease
14. In vivo muscle magnetic resonance spectroscopy in clinical investigations of mitochondrial disease
15. 31P-magnetic resonance spectroscopy
16. 31P magnetic resonance spectroscopy study
17. Anatomic and disease specificity of NADH CoQ1-reductase (complex I) in Parkinson's disease
18. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
19. Mitochondrial respiratory chain function in multiple system atrophy